论文标题
在网络荟萃分析中引入治疗层次结构问题
Introducing the treatment hierarchy question in network meta-analysis
论文作者
论文摘要
背景:使用网络荟萃分析的比较有效性研究可以呈现竞争性治疗的层次结构,从最少到最可取的选择。但是,与多个干预措施的层次结构相关的研究问题在发表的评论中从未明确定义。方法和结果:我们介绍了一个治疗层次结构问题的概念,该问题描述了选择特定处理的标准,而不是一种或多种竞争替代方案。例如,利益相关者可能会询问哪种治疗方法最有可能将平均生存率提高至少2年,或者哪种治疗方法与最长的平均生存期有关。这两个问题的答案不一定是相同的。我们讨论了最常用的排名指标(描述或比较估计的特定治疗效应的数量),指标如何产生治疗层次结构以及每个度量标准可以回答的处理层次结构问题的类型。我们表明,排名指标包括以不同方式估计治疗效果的不确定性,从而导致不同的治疗层次结构。结论:旨在对治疗进行排名的网络荟萃分析应在协议中指出他们旨在解决和采用适当的排名指标来回答的治疗等级问题。
Background: Comparative effectiveness research using network meta-analysis can present a hierarchy of competing treatments, from the least to most preferable option. However, the research question associated with the hierarchy of multiple interventions is never clearly defined in published reviews. Methods and Results: We introduce the notion of a treatment hierarchy question that describes the criterion for choosing a specific treatment over one or more competing alternatives. For example, stakeholders might ask which treatment is most likely to improve mean survival by at least 2 years or which treatment is associated with the longest mean survival. The answers to these two questions are not necessarily the same. We discuss the most commonly used ranking metrics (quantities that describe or compare the estimated treatment-specific effects), how the metrics produce a treatment hierarchy and the type of treatment hierarchy question that each metric can answer. We show that the ranking metrics encompass the uncertainty in the estimation of the treatment effects in different ways, which results in different treatment hierarchies. Conclusions: Network meta-analyses that aim to rank treatments should state in the protocol the treatment hierarchy question they aim to address and employ the appropriate ranking metric to answer it.